Monitoring of Artemisinin Combination Therapy in Igombe, Tanzania.

Monitoring of Artemisinin Combination Therapy in Igombe, Tanzania.

Bibliographic Details
Main Author:	Andersson, Johanna
Format:	Others
Language:	English
Published:	2014
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-234330

Similar Items

Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
by: Mwaka A. Kakolwa, et al.
Published: (2018-10-01)

Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania
by: Kamugisha Erasmus, et al.
Published: (2012-02-01)

Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
by: Montgomery Scott M, et al.
Published: (2008-10-01)

Molecular monitoring of <it>Plasmodium falciparum</it> resistance to artemisinin in Tanzania
by: Genton Blaise, et al.
Published: (2006-12-01)

The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania
by: Abdulla Salim, et al.
Published: (2008-01-01)

Increasing Access to Subsidized Artemisinin-based Combination Therapy through Accredited Drug Dispensing Outlets in Tanzania
by: Gabra Michael, et al.
Published: (2011-06-01)

Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework
by: Mori Amani, et al.
Published: (2012-03-01)

Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
by: Thalabard Jean-Christophe, et al.
Published: (2010-02-01)

Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
by: Shretta Rima, et al.
Published: (2012-12-01)

Community response to artemisinin-based combination therapy for childhood malaria: a case study from Dar es Salaam, Tanzania
by: Nyato Daniel J, et al.
Published: (2010-02-01)

Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania.
by: Oliver J Sabot, et al.
Published: (2009-09-01)

Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar
by: Ratsimbasoa Arsène, et al.
Published: (2007-05-01)

Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT)
by: Ringsted Frank M, et al.
Published: (2011-08-01)

Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
by: André Daher, et al.
Published: (2019-09-01)

Artemisinin combination therapy: a good antimalarial, but is the dose right?
by: Paul Garner
Published: (2013-12-01)

Access to artemisinin combination therapy for malaria in remote areas of Cambodia
by: Socheat Doung, et al.
Published: (2008-05-01)

From chloroquine to artemisinin-based combination therapy: the Sudanese experience
by: Elhassan AH, et al.
Published: (2006-07-01)

Cost of increasing access to artemisinin combination therapy: the Cambodian experience
by: Socheat Duong, et al.
Published: (2008-05-01)

Barriers to effectiveness : artemisinin combination therapies (ACTs) and the health system
by: Rao, Bhargavi
Published: (2015)

Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies.
by: Melissa A Briggs, et al.
Published: (2014-01-01)

Reduction of malaria prevalence after introduction of artemisinin-combination-therapy in Mbeya Region, Tanzania: results from a cohort study with 6773 participants
by: Guenter Froeschl, et al.
Published: (2018-06-01)

Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective
by: Dillip Angel, et al.
Published: (2010-06-01)

Who gets prompt access to artemisinin-based combination therapy? A prospective community-based study in children from rural Kilosa, Tanzania.
by: Daudi O Simba, et al.
Published: (2010-01-01)

Associated Factors to Uptake of Human Papiloma Virus Vaccine 2 Among Girls of Ages 9-14 Years in Igombe Sub-County Bugweri District.
by: Micheal Albert Olinga, et al.
Published: (2021-09-01)

Clinical Pharmacology of the Antimalarial Artemisinin-Based Combination and other Artemisinins in Children
by: Gian Maria Pacifici
Published: (2018-07-01)

Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapy
by: Ogouyèmi-Hounto Aurore, et al.
Published: (2016-01-01)

Brazilian <it>Plasmodium falciparum </it>isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy
by: Rosenthal Philip J, et al.
Published: (2010-12-01)

Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
by: Florian Kurth, et al.
Published: (2016-08-01)

Artemisinin-based combination therapy for uncomplicated <it>Plasmodium falciparum </it>malaria in Colombia
by: Taylor Walter RJ, et al.
Published: (2007-02-01)

The benefits of artemisinin combination therapy for malaria extend beyond the individual patient.
by: Paul Garner, et al.
Published: (2005-04-01)

Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!
by: Christian Nsanzabana
Published: (2019-02-01)

Artemisinin - From Traditional Chinese Medicine to Artemisinin Combination Therapies; Four Decades of Research on the Biochemistry, Physiology, and Breeding of Artemisia annua
Published: (2020)

Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study
by: Khatib Rashid A, et al.
Published: (2012-04-01)

Artemisinin Combination Therapy Can Result in Clinical Failure If Oral Therapy Is Not Directly Observed
by: Wilson W Chan, et al.
Published: (2013-01-01)

Artemisinin combination therapies price disparity between government and private health sectors and its implication on antimalarial drug consumption pattern in Morogoro Urban District, Tanzania
by: Malisa Allen, et al.
Published: (2012-03-01)

Do price subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania.
by: Jessica L Cohen, et al.
Published: (2013-01-01)

Editorial: Artemisinin—From Traditional Chinese Medicine to Artemisinin Combination Therapies; Four Decades of Research on the Biochemistry, Physiology, and Breeding of Artemisia annua
by: Tomasz Czechowski, et al.
Published: (2020-09-01)

Artemisinin-Based Combination Therapy Synergized with Medicinal Plants to Induce Musculotoxic Effects
by: Thérèse Daubrey-Potey, et al.
Published: (2021-01-01)

Artemisinin-based combination therapies (ACTs) and herbal drugs crosstalk: facts and perspectives
by: Randrianarivelojosia M., et al.
Published: (2009-09-01)

Optimum population-level use of artemisinin combination therapies: a modelling study
by: Tran Dang Nguyen, BSc, et al.
Published: (2015-12-01)